Elsevier

The Lancet

Volume 309, Issue 8015, 9 April 1977, Pages 806-807
The Lancet

Letters to the Editor
SERUM-25-HYDROXYCHOLECALCIFEROL IN HYPERTHYROIDISM

https://doi.org/10.1016/S0140-6736(77)92995-6Get rights and content

References (5)

  • C. Velentzas et al.

    Lancet

    (1977)
  • M.S. Christensen

    Scand. J. clin. Lab. Invest.

    (1976)
There are more references available in the full text version of this article.

Cited by (22)

  • Hypovitaminosis D and bone mineral metabolism and bone density in hyperthyroidism

    2010, Journal of Clinical Densitometry
    Citation Excerpt :

    In another study from Japan, Doi et al showed that 35% patients with thyrotoxicosis have vitamin D deficiency (17). However, no previous studies have reported such a high prevalence of low serum 25(OH) D levels resulting in osteomalacia (18,19). Mosekilde et al (18) conducted bone biopsies in 34 patients with hyperthyroidism.

  • Hypovitaminosis D in acutely injured pediatric burn patients

    2004, Journal of the American Dietetic Association
    Citation Excerpt :

    The effect of thyroxine therapy on bone health in burns is unknown. In other populations, however, hyperthyroidism as well as overzealous thyroxine replacement has been associated with accelerated epiphyseal closure (149) and also deleterious consequences on bone mineral density (155,156) and reduced D25 concentrations (157). Finally, suboptimal vitamin D status may have persisted during the course of the study due to an absorption defect or, alternatively, ineffective supplementation practices.

View all citing articles on Scopus
View full text